19 results on '"Van der Ven,Andre"'
Search Results
2. Non-AIDS Events in Individuals With Spontaneous Control of HIV-1: A Systematic Review
3. Plasmatic Coagulation Capacity Correlates With Inflammation and Abacavir Use During Chronic HIV Infection
4. A switch to a raltegravir containing regimen does not lower platelet reactivity in HIV-infected individuals
5. Lower Ribavirin Plasma Concentrations in HCV/HIV–Coinfected Patients Than in HCV-Monoinfected Patients Despite Similar Dosage
6. Reduced platelet hyperreactivity and platelet-monocyte aggregation in HIV-infected individuals receiving a raltegravir-based regimen
7. Prevalence of Lipodystrophy in HIV-infected Children in Tanzania on Highly Active Antiretroviral Therapy
8. Intrapartum Single-Dose Carbamazepine Reduces Nevirapine Levels Faster and May Decrease Resistance After a Single Dose of Nevirapine for Perinatal HIV Prevention
9. No Changes in Efavirenz Plasma Concentrations in HIV-Infected Patients Who Switch From Stocrin to Atripla
10. Imaging of HIV-Associated Kaposi Sarcoma; F-18-FDG-PET/CT and In-111-Bevacizumabscintigraphy
11. Lower atovaquone/proguanil concentrations in patients taking efavirenz, lopinavir/ritonavir or atazanavir/ritonavir
12. The effect of HIV infection on adult meningitis in Indonesia: a prospective cohort study
13. Efavirenz dose reduction to 200 mg once daily in a patient treated with rifampicin
14. The toll-like receptor 4 Asp299Gly variant and tuberculosis susceptibility in HIV-infected patients in Tanzania
15. Brief Report: Enzyme Inducers Reduce Elimination Half-Life After a Single Dose of Nevirapine in Healthy Women
16. Human intestinal spirochaetosis
17. Herpes Viruses, Cytokines, and Altered Hemostasis in Vital Exhaustion
18. Central nervous system symptoms related to the use of efavirenz in HIV-seropositive patients
19. Cerebral vasculitis after initiation antiretroviral therapy
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.